[Comparative double-blind study of a 0.1% hydrocortisone-17-butyrate cream (Locoid) and a 0.1% betamethasone-17-valerate cream (Betnovate) in patients with noninfected eczema].
D000328:Adult; D001623:Betamethasone / Q000031:analogs & derivatives*; D001624:Betamethasone Valerate / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004485:Eczema / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D009824:Ointments
D009824:Ointments; C007975:hydrocortisone-17-butyrate; D001623:Betamethasone; D001624:Betamethasone Valerate; D006854:Hydrocortisone
Vergleichende Doppelblinduntersuchung einer 0,1%-Crème von Hydrocortison-17-butyrat (Locoid) gegenüber einer 0,1%-Crème von Betamethason-17-valerat (Betnovate) bei Patienten mit nichtinfizierten Ekzem.